tag:blogger.com,1999:blog-22081536972994854102024-02-18T23:40:17.353-08:002nd Middle East Obesity, Bariatric Surgery and Endocrinology Congress2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.comBlogger11125tag:blogger.com,1999:blog-2208153697299485410.post-14670130040652927032019-04-26T01:51:00.001-07:002019-04-26T01:51:25.266-07:00Genetics of Obesity<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj8qifmKBuV6OS7mKXPE_0FhYnnlb3YMGSYtLScJ_IJNu4JhGzhyphenhyphenOkpvMkyh7Cgf1Pbqs7pIP2EAo8R9wpd076-OYOenGgAEyfp-LOCvWNGBnOgV_jBYXGpwbQ8kzCC9Plg_Pg9BZK2JD6i/s1600/2nd+Middle+East+Obesity%252C+Bariatric+Surgery+and+Endocrinology+Congress.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="512" data-original-width="1024" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj8qifmKBuV6OS7mKXPE_0FhYnnlb3YMGSYtLScJ_IJNu4JhGzhyphenhyphenOkpvMkyh7Cgf1Pbqs7pIP2EAo8R9wpd076-OYOenGgAEyfp-LOCvWNGBnOgV_jBYXGpwbQ8kzCC9Plg_Pg9BZK2JD6i/s640/2nd+Middle+East+Obesity%252C+Bariatric+Surgery+and+Endocrinology+Congress.jpg" width="640" /></a></div>
<div class="lead" style="background: white; margin-bottom: 15.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
<br /></div>
<div class="lead" style="background: white; margin-bottom: 15.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
In the largest study of
it's kind to date, researchers have looked at why a few people manage to stay
thin while others gain weight easily. They have discovered that the hereditary
dice are loaded in favour of thin people and against those at the obese end of
the spectrum.More than six in ten adults are
overweight, and one in four adults is obese. By age five, almost one in four
children is either obese or overweight. Excess weight increases the risk of
related health problems including heart disease and <a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-diabetes">type
2 diabetes</a>. </div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
While it is well known that changes in our
environment, for example, easy access to high-calorie foods and sedentary
lifestyles, have driven the rise in obesity in recent years, there is
considerable individual variation in weight inside a populace that shares the
same environment. A few people seem able to eat what they like and remain thin.
This has led a few people to characterise overweight people as lazy or lacking
willpower. <o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
The researchers examine why and how some
people find it easier to stay thin than others. Studies of twins have demonstrated
that variation in body weight is generally affected by our genes. To date
studies have overwhelmingly focused on people who are overweight. Hundreds of
genes have been discovered that increase the possibility of an individual being
overweight and in some people faulty genes can cause severe obesity from a
young age.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
Our DNA contains of a sequence of
molecules known as base pairs, represented by the letters A, C, G and T.
Strings of these base pairs form genetic regions. Our genes provide the code
for how our body functions and changes in the spelling. <o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
The team found a few regular genetic
variants already identified as playing a role in <a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-its-causes">obesity</a>.
Moreover, they found new genetic regions involved in severe obesity and some
involved in healthy thinness. <o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
To see what impact these genes had on an
individual’s weight, the specialists included the contribution of the different
genetic variants to calculate a genetic risk score. As anticipated, we found
that obese people had a higher genetic risk score than normal weight individuals,
which contributes to their risk of being overweight. The genetic dice are
loaded against them. <span style="mso-spacerun: yes;"> </span><o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
Importantly, the team also showed that
thin individuals, had a much lower hereditary risk score they had less genetic
variants that we know increased an individual's chances of being overweight.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
This examination shows for the first time
that healthy individuals are commonly thin because they have a lower burden of
genes that increase an individual's chances of being overweight and not because
they are morally superior, as certain individuals like to suggest. It's easy to
rush to judgement and criticise individuals for their weight, but the science
shows that things are far more complex. We have far less power over our weight
than we may wish to think.<span style="mso-spacerun: yes;"> </span><span style="mso-spacerun: yes;"> </span><o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
We already know that individuals can be
thin for various reasons. A few individuals are just not that interested in
food whereas others can eat what they like, but never put on weight. If we can
find the genes that prevent them from putting on weight, we might most likely
focus on those genes to discover new weight loss strategies and help individuals
who do not have this advantage.</div>
<br />
<div style="margin: 0px;">
Contact details:</div>
<div style="text-align: justify;">
</div>
<div style="text-align: justify;">
Alina Grace</div>
<div style="text-align: justify;">
Program Manager | Obesity Middle East 2019</div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12pt; line-height: 18.4px;"></span></div>
<div style="text-align: justify;">
Email Id: obesityendo@mehealthevents.org</div>
</div>
2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.com1tag:blogger.com,1999:blog-2208153697299485410.post-88905422514974709592019-04-13T00:08:00.001-07:002019-04-13T00:08:50.973-07:00Vitamin D supplements may promote weight reduction in obese children<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj-aFUtNDXVzS1chy-CWkvRRUBJKlqCSKKJARUreEZMdsx5i7JmmjWR1N_YH0Amk-WodDVcGQZfyr6kkt5HbB-YlYVUiE-BePSoJzkHpApxrIk8zzwZs1E8pjNK3AL3mZNlSrPxUYc2-hqC/s1600/Fashion+Collection.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="900" data-original-width="1600" height="360" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj-aFUtNDXVzS1chy-CWkvRRUBJKlqCSKKJARUreEZMdsx5i7JmmjWR1N_YH0Amk-WodDVcGQZfyr6kkt5HbB-YlYVUiE-BePSoJzkHpApxrIk8zzwZs1E8pjNK3AL3mZNlSrPxUYc2-hqC/s640/Fashion+Collection.jpg" width="640" /></a></div>
<div class="lead" style="background: white; margin-bottom: 15.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
<br /></div>
<div class="lead" style="background: white; margin-bottom: 15.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
Vitamin D supplements may promote weight loss and reduce risk factors for future heart and metabolic disease in obese and overweight children. The findings indicate that vitamin D is the simple supplementation may be part of an effective strategy to tackle <a href="https://obesity-middleeast.conferenceseries.com/events-list/childhood-obesity-and-effects">childhood obesity</a> and reduce the risk of serious health problems, such as heart disease, in adulthood.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
<a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-its-causes">Obesity</a> in childhood and adolescence represents a major health problem worldwide, which leads to the development of expensive, debilitating and serious complications, including diabetes and heart disease, in later life. Vitamin D deficiency is stereotypically associated with impaired bone health, in recent years it has been increasingly linked with increased body fat accumulation and obesity, with the precise nature of this relationship currently under intense investigation by scientists. However, the effect of vitamin D supplementation on the health and weight of obese children and adolescents had not yet been investigated.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
In this study, researchers assessed 232 obese children and adolescents over 1 year, with 117 randomly assigned to receive vitamin D supplementation, in accordance with the guidelines on treatment and prevention of deficiency. Levels of vitamin D, body fat, and blood markers of liver function and heart health were assessed at the start of the study and 12 months later. The study reported that children given vitamin D supplements had significantly lower BMI, body fat and improved cholesterol levels after a year of supplementation.<span style="background: yellow; mso-highlight: yellow;"><o:p></o:p></span></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
These findings suggest that simple vitamin D supplementation may reduce the risk of obese and overweight children developing serious heart and metabolic complications in later life.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
The team now plan to investigate the effects of vitamin D supplementation on the health of obese children and adolescents that already have unhealthy conditions, such as high blood pressure, high cholesterol and high blood glucose all of which increase the risk of heart disease, stroke and <a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-diabetes">diabetes</a>.<o:p></o:p></div>
<span style="background-color: white; text-align: justify;">Although these initial findings indicate that vitamin D could be used in the treatment of obesity, there remains a lack of evidence on the safety and long-term effects of supplementation, particularly if there is no vitamin D deficiency. However, if your child is obese or overweight I recommend that you consult your primary care physician for advice, and consider having their vitamin D levels tested.</span><br />
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
<o:p></o:p></div>
<div style="text-align: justify;">
Contact details:</div>
<div style="text-align: justify;">
Alina Grace</div>
<div style="text-align: justify;">
Program Manager | Obesity Middle East 2019</div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12pt; line-height: 18.4px;"></span></div>
<div style="text-align: justify;">
Email Id: obesityendo@mehealthevents.org</div>
</div>
2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.com3tag:blogger.com,1999:blog-2208153697299485410.post-7841866560665972772019-04-05T01:00:00.001-07:002019-04-05T01:01:17.993-07:00Endocrine cells in the brain impact the optimization of behavior<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEicwYXtPIykVZiR8FX36bANqbUBfuAFien0MCowT3XMasW10hioZVWsK4zxdCzGERLvoaoAGZccesVKRLNl0PRrYs7PI2HcVVHaaIxTfr-DvzyA-XxY7aFXe6J4GWPfVYrmz1puBw_9izs5/s1600/Obesity+Middle+East+2019+Blog.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="512" data-original-width="1024" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEicwYXtPIykVZiR8FX36bANqbUBfuAFien0MCowT3XMasW10hioZVWsK4zxdCzGERLvoaoAGZccesVKRLNl0PRrYs7PI2HcVVHaaIxTfr-DvzyA-XxY7aFXe6J4GWPfVYrmz1puBw_9izs5/s640/Obesity+Middle+East+2019+Blog.jpg" width="640" /></a></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">An individual exposed to stress can usually rapidly adapt the own behavior to the specific situation. Biochemical messenger substances in the brain play a central role in this rapid transformation process. We know that hormones additionally have a stress regulating function, but that their effects are more slowly apparent. Using a combination of optical and genetic techniques, the research team has had the capacity to show that corticotrophs, the cell populations that prompts the adrenal cortex and produce the stress hormones of the hypothalamic-pituitary-adrenal axis, will quickly impact avoidance behavior immediately after the onset of a stress situation. This insight could add to the development of effective treatments which will facilitate the management of acute stress induced reactions or may even have the capacity to mitigate acute stress associated conditions. <o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">The human body is controlled by the hormonal system and the nervous system. The hypothalamus situated in the middle of the basis of the brain has a key role here providing the link between the body and the different regions of the brain similarly as directly and indirectly controlling a progression of essential physiological vegetative functions. In addition, it is the most important control organ of the human </span><a href="https://obesity-middleeast.conferenceseries.com/events-list/endocrinology"><span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">endocrine system</span></a><span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">, because it regulates when and how much of a hormone is produced. Both the hypothalamus and its production of hormone are also subject to the impacts of emotional stress. The pituitary gland is connected to the hypothalamus and together they form a single functional unit called the hypothalamic-pituitary-adrenal axis.<o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Hormones secreted by the hypothalamus incorporate the supposed releasing hormones, such as the corticotropin-releasing hormone. This stimulates the production of the adrenocorticotropic hormone in the pituitary gland. The adrenocorticotropic hormone is a hormone secreted by the anterior lobe of the pituitary and it regulates the production of other hormones, such as the stress hormone cortisol.<o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">It can be basically assumed that the neurotransmitters of the CNS quickly determine whether fight or flight behavior is to develop in a given situation. To date, medical science has conjectured that the stress-regulating effects of the hormones of the HPA axis come into play far more slowly. Stress researchers found it very problematic to establish the concrete role of the hypothalamic-pituitary-adrenal axis in the rapid adaptation of behavior in a stress situation in more detail in standard animal models. This is because the location of the pituitary gland and hypothalamus in mammals makes them difficult to access. To overcome these obstacles, the researcher decided to create an innovative optogenetic research technique. They managed to develop a hereditarily modified zebrafish larva in which they had the capacity to manipulate the activity of the HPA axis using light and subsequently observe the resultant changes to the responses of the altered cells. <o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">The researchers introduced a synthetic enzyme into their animal model that elevates the levels of the intracellular messenger substance cyclic adenosine monophosphate (cAMP) only in the corticotropic cells of the hypothalamic-pituitary-adrenal axis. Their rise is important for the release of hormones in the corticotropic cells of the anterior pituitary. The levels of the resulting so-called transgenetic animal stress hormones can be increased by means of exposure to light. This means the researchers can thus observe the accompanying changes to behavior. <o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<span style="font-family: "times new roman", serif; font-size: 12pt; text-align: justify;">The recently published research results that the corticotropic cells in the pituitary become directly active on the beginning of a stress situation that is seen as distressing. These then influence locomotion and avoidance behavior as well as the sensitivity to the stimulus. The specialists translate this as proof that the corticotropic cells in the pituitary play a significant role in the rapid adaptation of behavior to local environments identified as antagonistic. </span><br />
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div style="text-align: justify;">
Contact details:</div>
<div style="text-align: justify;">
Alina Grace</div>
<div style="text-align: justify;">
Program Manager | Obesity Middle East 2019</div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"></span></div>
<div style="text-align: justify;">
Email Id: obesityendo@mehealthevents.org</div>
</div>
2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.com0tag:blogger.com,1999:blog-2208153697299485410.post-16255946821060075902019-03-22T04:05:00.000-07:002019-03-22T04:06:32.374-07:00Everything you need to know about gene therapy shown to cure type 2 diabetes and obesity in mice, researchers report<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgvHOpw2-VKhaiybtqOlQ0kC0-xljsDV0I5L4m5kXBaLRpr09n8uX2S55e-v-K_uTPxith0x-AiLOdT02-38Ez4sdYbXwXkutBbCBjQdNPvdbBzh1ZDUUd8dtvIE5ZD89LncX4GSjgUf4Xl/s1600/Obesity+Middle+East+2019+%25286%2529.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="413" data-original-width="813" height="324" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgvHOpw2-VKhaiybtqOlQ0kC0-xljsDV0I5L4m5kXBaLRpr09n8uX2S55e-v-K_uTPxith0x-AiLOdT02-38Ez4sdYbXwXkutBbCBjQdNPvdbBzh1ZDUUd8dtvIE5ZD89LncX4GSjgUf4Xl/s640/Obesity+Middle+East+2019+%25286%2529.jpg" width="640" /></a></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
<br /></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
A single supervision of an adeno-associated viral vector booming the Fibroblast Growth Factor 21 gene resulted in genetic manipulation of the liver, skeletal muscle or adipose tissue to rapidly enhance Fibroblast Growth Factor 21 protein. This protein is a hormone secreted naturally by several organs that acts on many tissues for the maintenance of correct energy metabolism. By inducing FGF21 production through gene therapy the animal lost weight and decreased insulin resistance, this causes the development of <a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-diabetes">type 2 diabetes</a>.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
The therapy has been tested successfully in two different mouse models of obesity, induced either by genetic mutations or diet. Also, the researchers scrutinized that when administered to healthy mice, the gene therapy endorsed healthy aging and prevented age associated weight gain and insulin resistance.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
After treatment with adeno-associated viral- Fibroblast Growth Factor 21, mice lost weight and reduced fat accumulation and inflammation in adipose tissue; steatosis, fibrosis and inflammation of the liver were also reversed. This led to an increase in healthy aging and in insulin sensitivity without any adverse side effects.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
The results have been reproduced after genetic manipulation of three different tissues to produce the Fibroblast Growth Factor 21. This gives flexibility to the treatment, since it permits to choose each time the most appropriate tissue and in case some impediment prevents manipulating any of the tissues, it can be applied to any of the others. When a tissue produces Fibroblast Growth Factor 21 protein and secretes it into the bloodstream, it will be distributed throughout the body. <o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
The authors highlight the significance of these results, since the prevalence of type 2 diabetes and obesity is growing at alarming rates around the world. Obesity also enhances the risk of mortality and indicates an important risk factor for neurodegenerative disorders, <a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-cardiovascular-disease">cardiovascular</a> and immune diseases, arthritis, hypertension, and some types of cancer. <o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
The results also reveal that the scrutinization of the gene therapy ensured against the risk of tumor formation in the liver in response to a hyper caloric diet for a prolonged period of time.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
The native Fibroblast Growth Factor 21 protein has a short half-life when administered using conventional procedures. For this reason, the pharmaceutical industry has developed Fibroblast Growth Factor 21 analogues and has already conducted clinical trials. Fibroblast Growth Factor 21 mimetics, however require periodic administration to mediate clinical advantages and but may raise immunological issues related to the administration of exogenous proteins. The gene therapy vectors used by researcher, however, induce the mice to produce for many years the same FGF21 hormone naturally produced by the body, after a single administration and without any adverse effects. <o:p></o:p></div>
<span style="background-color: white; text-align: justify;">For </span>scientist<span style="background-color: white; text-align: justify;"> the next step will be to test this therapy in larger animals before moving to clinical trials with patients. AAV-mediated gene therapy has been approved for the treatment of several diseases, due to its efficacy and safety profile. Similarly, there exists extensive clinical experience in applying </span>adeno<span style="background-color: white; text-align: justify;"> associated viral-mediated gene transfer to </span>liver<span style="background-color: white; text-align: justify;"> and skeletal muscle. Subsequently, the therapy described in this study comprises the basis for the future clinical translation of Fibroblast Growth Factor 21 gene transfer to treat </span><a href="https://obesity-middleeast.conferenceseries.com/events-list/genetics-of-obesity" style="background-color: white; text-align: justify;">obesity</a><span style="background-color: white; text-align: justify;">, type 2 diabetes, and related comorbidities. </span><br />
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
<o:p></o:p></div>
<div style="text-align: justify;">
Contact details:</div>
<div style="text-align: justify;">
Alina Grace</div>
<div style="text-align: justify;">
Program Manager | Obesity Middle East 2019</div>
<div style="text-align: justify;">
Email Id: obesityendo@mehealthevents.org</div>
</div>
2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.com0tag:blogger.com,1999:blog-2208153697299485410.post-23120305469166233652019-03-15T01:04:00.002-07:002019-03-15T01:16:58.839-07:00The ultimate revelation of Obesity and Cognitive Function<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh8BJG24sXHGCyEGlWTFlCHWN-PKa5KmvU4ZguwZGNoy2K8gPreatdAzR0bdbR99QhxDZhUpnvC30J5pkPZd092B__oo94xgD2OrFBjGwrHwRl5CNLcXcSndxjXRgy_Sw1KTZTv7HQVAhB7/s1600/https___obesity-middleeast.conferenceseries.com_.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="430" data-original-width="813" height="338" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh8BJG24sXHGCyEGlWTFlCHWN-PKa5KmvU4ZguwZGNoy2K8gPreatdAzR0bdbR99QhxDZhUpnvC30J5pkPZd092B__oo94xgD2OrFBjGwrHwRl5CNLcXcSndxjXRgy_Sw1KTZTv7HQVAhB7/s640/https___obesity-middleeast.conferenceseries.com_.jpg" width="640" /></a></div>
<div class="lead" style="background: white; margin-bottom: 15.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
<br /></div>
<div class="lead" style="background: white; margin-bottom: 15.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
High intensity interval exercise is commonly recognized as the most time effective and efficient way to exercise. It could likewise be an effective strategy to prevent and combat <a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-cognitive-function">cognitive dysfunction</a> in obese individuals. <o:p></o:p></div>
<div class="lead" style="background: white; margin-bottom: 15.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
Obesity reduces the expression of brain-derived neurotrophic factor, a protein in the brain that promotes the survival of neurons. Lower levels of this protein are associated with Parkinson's disease, Alzheimer's disease, and <a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-its-causes">obesity</a>. Although research has shown that obesity is a risk factor for cognitive dysfunction, the mechanisms of this relationship are not fully understood.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
To-date, studies on exercise and brain-derived neurotrophic factor response in obese individuals have only used continuous moderate intensity exercise without rest intervals. The researchers examine the modulatory role of obesity on exercise-induced BDNF release and to use an acute high-intensity interval exercise protocol as a practical model to measure the phenomena of brain-derived neurotrophic factor response release in both obese and normal-weight subjects. They also examined the potential relationship of an exercise-induced brain-derived neurotrophic factor with blood lactate and cortisol. <o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
Results of study, show that the brain-derived neurotrophic factor response to acute high intensity interval exercise was greater than continuous moderate-intensity exercise in obese subjects when compared to normal weight subjects. These findings recommend that acute high intensity interval exercise may be a more effective protocol to upregulate brain derived neurotrophic factor expression in an obese population, cortisol levels and independent of increased lactate.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
Other findings from the study show statistically significant differences between the obese and normal weight groups for body weight, body mass index, systolic and diastolic blood pressures, and waist circumferences and ratio. Also, both the normal and obese weight groups had comparable heart rate responses during both exercise protocols, producing a similar relative exercise intensity and effort between groups. Therefore, the brain-derived neurotrophic factor response was likely not influenced by disparities between aerobic fitness, with a greater level in obese subjects than normal weight subjects following acute high intensity interval exercise vs. continuous moderate intensity exercise.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
Also, both the fat and typical weight bunches had equivalent pulse reactions amid both exercise conventions, delivering a comparable relative exercise power and exertion between gatherings.<o:p></o:p></div>
<div style="background: white; margin-bottom: 7.5pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm; text-align: justify;">
Increased levels of cortisol have been shown to down regulate brain-derived neurotrophic factor expression; however, this relationship in response to exercise still remains equivocal. Specifically, our study and others did not observe any correlation between cortisol and brain-derived neurotrophic factor following either acute high-intensity exercise or continuous moderate-intensity exercise protocol, yet, the report of such is opposite.<o:p></o:p></div>
<span style="background-color: white; font-family: "times new roman" , serif; font-size: 12pt; text-align: justify;">For more details, please visit</span><span style="background-color: white; color: #333333; font-family: "times new roman" , "serif"; font-size: 12pt; text-align: justify;"> <a href="https://obesity-middleeast.conferenceseries.com/call-for-abstracts.php">Obesity Middle East 2019</a></span><br />
<br />
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 7.5pt; text-align: justify;">
Contact details:<br />
Alina Grace<br />
Program Manager | Obesity Middle East 2019<br />
Email id: obesityendo@mehealthevents.org</div>
</div>
2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.com0tag:blogger.com,1999:blog-2208153697299485410.post-11984638284760115962019-02-16T00:06:00.000-08:002019-02-16T00:09:08.985-08:00Fatness versus fitness: which matters more?<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg25LErvB431_EQhba-A7vuEDc8EiBasZR9owcvtoWS8ua5jE-SbUAJVlpKfokPzphZY88nL4TQVVm8Zr4iNewuluP2qW7KCyXvWWsT0IQTUxspVjloHrt9J1LTSVZP7Mn356fPs_ODpngd/s1600/https___obesity-middleeast.conferenceseries.com.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="255" data-original-width="255" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg25LErvB431_EQhba-A7vuEDc8EiBasZR9owcvtoWS8ua5jE-SbUAJVlpKfokPzphZY88nL4TQVVm8Zr4iNewuluP2qW7KCyXvWWsT0IQTUxspVjloHrt9J1LTSVZP7Mn356fPs_ODpngd/s320/https___obesity-middleeast.conferenceseries.com.jpg" width="320" /></a></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Numerous studies have looked at fitness and obesity as two separate elements because they are apparently separate ideas: one measures how well your lungs and heart work to supply oxygen to your muscles while the other is a proportion of your body height and weight. However, the measures of fitness and fatness are both influenced by how much you weigh. <o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Likewise, what researchers mean by fatness is really body mass index (BMI), a measure of body fat based on height and weight. Strictly speaking, </span><a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-its-causes"><span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">obesity</span></a><span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"> doesn’t mean you are automatically unfit. There are fat people who run every day, and then there are thin people who couldn’t run a mile for their life. A muscular individual can also be considered obese, because muscle weighs over fat, and be very fit.<o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">But these are exceptions, not the rule. Studies demonstrate that when someone is considered as obese, the probability of them being fit is very low. So in our society, being fat still generally means lower fitness. <o:p></o:p></span></div>
<h2>
<span style="color: windowtext;">Fatness makes it harder to enhance fitness<o:p></o:p></span></h2>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">For people who are obese, concentrating on losing weight is a better place to start than just focusing on fitness. That is as a result of extra weight can make it harder to move, and thus harder to exercise. Obese people typically have a difficult time doing physical activity due to limited mobility, body size and joint pain.<o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Physiologically, it’s harder for an obese individual to do the same amount of exercise as a healthy weight individual because of the extra weight they carry. Heavier individuals need more oxygen to do the same exercise as a healthy weight person. Some obese individuals report that even walking can seem difficult. Fitness is just harder to achieve if you can’t move effectively.<o:p></o:p></span></div>
<h2>
<span style="color: windowtext;">Fatness reduces the quality of life<o:p></o:p></span></h2>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">The debate around fitness and fatness centres on studies that show that compared to normal weight-fit individuals, unfit individuals had twice the risk of mortality regardless of BMI. But as these studies show, a relatively small proportion of people are fit and obese.<o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">But mortality is not the only issue. Obesity has been shown to predict heart disease, liver disease, </span><a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-diabetes"><span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">diabetes</span></a><span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"> and a whole host of health problems that will need taking daily pills or having daily injections or result in invasive procedures. Even if a higher BMI does not predict earlier death, this doesn’t mean that it doesn’t matter to your health.<o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<span style="font-family: "times new roman", serif; font-size: 12pt; text-align: justify;">Increasing physical activity while not losing weight won't probably improve these patients’ lives. To enhance their health and quality of life, it is important to exercise every day, eat healthy food and most importantly lose some weight.</span></div>
2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.com0tag:blogger.com,1999:blog-2208153697299485410.post-49941977966156635672019-02-01T01:37:00.001-08:002019-02-01T01:37:12.421-08:00Endocrine disorder is most common cause of elevated calcium levels<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 15.0pt; text-align: justify;">
<span style="font-family: "Times New Roman", serif; font-size: 12pt;">Unusually high calcium levels in the blood can quite often be followed to essential </span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN;">hyperparathyroidism</span><span style="font-family: "Times New Roman", serif; font-size: 12pt;">, an undertreated, underreported condition that influences predominantly women and the elderly, according to a new study by researchers.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 7.5pt; text-align: justify;">
<span style="font-family: "Times New Roman", serif; font-size: 12pt;">The condition, which results from overactive parathyroid glands and includes symptoms of bone loss, depression and fatigue that may go undetected for years, is most often seen in women over the age of 50, the researchers discovered.<o:p></o:p></span></div>
<br />
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 7.5pt; text-align: justify;">
<span style="font-family: "Times New Roman", serif; font-size: 12pt;">The four parathyroid glands, which are situated in the neck, next to the thyroid, control the body's calcium levels. When one is dysfunctional, it can cause major imbalances - for example, by releasing calcium from the bones and into the circulatory system. Over time, calcium loss from bones often prompts to </span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN;">osteoporosis</span><span style="font-family: "Times New Roman", serif; font-size: 12pt;"> and fractures, and excessive calcium levels in the blood can cause kidney stones and worsening kidney function. </span></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj77xPTwz1kBXUyrlErr5vkIBWHr4pw1cvbQlqLIJSv4gu1IC3jk5aowtSvu0XJIE2Jrj6YhA435zj4sMnpEn6QFbGGhcWSxzra6U83GLbCPNbHwdfKElacX9M9tfg9YfbSmixq-tNGQzdz/s1600/Obesity+Middle+East+2019+%25289%2529.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><span style="color: black;"><img border="0" data-original-height="479" data-original-width="662" height="462" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj77xPTwz1kBXUyrlErr5vkIBWHr4pw1cvbQlqLIJSv4gu1IC3jk5aowtSvu0XJIE2Jrj6YhA435zj4sMnpEn6QFbGGhcWSxzra6U83GLbCPNbHwdfKElacX9M9tfg9YfbSmixq-tNGQzdz/s640/Obesity+Middle+East+2019+%25289%2529.jpg" width="640" /></span></a></div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 7.5pt; text-align: justify;">
<span style="font-family: "Times New Roman", serif; font-size: 12pt;"><br /></span></div>
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 7.5pt; text-align: justify;">
<span style="font-family: "Times New Roman", serif; font-size: 12pt;">The researchers determined that hyperparathyroidism is the leading cause of high blood-calcium levels and is responsible for nearly 90 percent of all cases. The findings suggest that hyperparathyroidism is the predominant reason for high calcium levels, so if patients discover they have high calcium, they should also have their parathyroid hormone level checked. Hyperparathyroidism, which influences approximately 1 percent of the population, can be identified by measuring parathyroid hormone levels to determine if they are elevated or abnormal.</span><span style="font-family: "Times New Roman", serif; font-size: 12pt;"> </span></div>
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 7.5pt; text-align: justify;">
<span style="font-family: "Times New Roman", serif; font-size: 12pt;">The researchers noted that the growing prevalence is likely due to increased calcium testing, annual lab tests to monitor patients with indications and the low rate of surgery to treat the disorder. Previous studies have shown that only 28% of patients with hyperparathyroidism undergo surgery to remove the overactive parathyroid gland - the most reliable way to correct the disorder. Women can suffer over years with hyperparathyroidism and not know they have it, which is especially critical in midlife when bone health is so critical. Appropriate management of the disorder is essential. Surgery should be considered in most of the individuals with primary hyperparathyroidism. <o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 7.5pt; text-align: justify;">
<span style="font-family: "Times New Roman", serif; font-size: 12pt;">The scientists noticed that the developing pervasiveness is likely because of expanded calcium testing, yearly lab tests to screen patients with indications and the low rate of medical procedure to treat the confusion. Past research has appeared just 28 percent of patients with hyperparathyroidism experience medical procedure to expel the overactive </span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN;">parathyroid organ - the most solid approach to address the turmoil. Ladies can languish over years with hyperparathyroidism and not realize they have it, which is particularly basic in midlife when bone wellbeing is so critical. Suitable administration of the turmoil is fundamental. Medical procedure ought to be considered in most of the individuals with essential hyperparathyroidism.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 7.5pt; text-align: justify;">
<span style="font-family: "Times New Roman", serif; font-size: 12pt;">The next step, the researcher said that further study of this patient population to examine the long-term impact of the condition on bone health and the effectiveness of different management strategies on outcomes.<o:p></o:p></span></div>
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 7.5pt; text-align: justify;">
<span style="font-family: "Times New Roman", serif; font-size: 12pt;">For more details, please visit</span><span style="color: #333333; font-family: "Times New Roman","serif"; font-size: 12.0pt; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN;"> <a href="https://obesity-middleeast.conferenceseries.com/call-for-abstracts.php">Obesity Middle East 2019</a></span></div>
<div class="MsoNormal" style="background: white; line-height: normal; margin-bottom: 7.5pt; text-align: justify;">
Contact details:<br />Alina Grace<br />Program Manager | Obesity Middle East 2019<br />Email id: obesityendo@mehealthevents.org</div>
</div>
2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.com0tag:blogger.com,1999:blog-2208153697299485410.post-55348099625907154542019-01-25T03:17:00.001-08:002019-01-25T03:17:20.869-08:00Diabetes in relation with cardiovascular diseases<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgfpBSg-YBYPgbLxGniMFVdHffjGigT3nzb21zA8bRN_n1oeC4izkK01GcEvPdnLWrSudlLK79HswMT_FbayBY_dY-anybMuLb-RBc2mIRxTr0brYb2KLXve-Sh5yvXQPCavLvijiRrUutD/s1600/Obesity+Middle+East+2019+%25284%2529.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="625" data-original-width="1000" height="400" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgfpBSg-YBYPgbLxGniMFVdHffjGigT3nzb21zA8bRN_n1oeC4izkK01GcEvPdnLWrSudlLK79HswMT_FbayBY_dY-anybMuLb-RBc2mIRxTr0brYb2KLXve-Sh5yvXQPCavLvijiRrUutD/s640/Obesity+Middle+East+2019+%25284%2529.jpg" width="640" /></a></div>
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="background: white; font-family: "Times New Roman", serif; font-size: 12pt; line-height: 115%;"><a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-diabetes">Diabetes</a> is an important chronic disease which incidence is globally increasing and however considered as an epidemic. This growth in diabetes prevalence, driven principally by an increased prevalence of type 2 diabetes (T2D), is occurring in both developing and developed countries. The incidence of type 1 diabetes (T1D) is also increasing in parallel to that of T2D worldwide.</span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"> Individuals with diabetes and with chronically poor metabolic control can experience micro vascular and macro vascular complications leading to a significant burden for the individual and for the society. This burden includes direct costs of medical care and indirect costs, such as loss of productivity, which result from diabetes-related morbidity and premature mortality Health care expenses for people with diabetes is more than double of that for people without diabetes; the direct and indirect expenditures attributable to diabetes. The International Diabetes Federation (IDF) estimated that diabetes accounts for 5–10% of the total healthcare budget in many countries. <o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="background: white; font-family: "Times New Roman", serif; font-size: 12pt; line-height: 115%;"><a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-cardiovascular-disease">Cardiovascular diseases</a> are the most prevalent cause of mortality and morbidity among people with T2D and T1D. The presence of cardiovascular diseases and stroke was found in 68% and 16% of deaths related to diabetes among people older than 65 years, respectively. Adult individuals with diabetes present rates of mortality because of heart disease and stroke from two to four times higher than those without diabetes</span><span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">. It has been stated that patients with T2D without a previous history of myocardial infarction have the same risk of coronary artery disease as nondiabetic subjects with a history of myocardial infarction. However, there is still some uncertainty as to whether the cardiovascular risk given by diabetes is truly equivalent to that of a previous myocardial infarction. In general, patients with diabetes aggregate other comorbidities such as obesity, hypertension, and dyslipidemia which also contribute to increasing the risk for <span style="background: white;">cardiovascular diseases</span>. Although there is strong evidence that supports both the efficacy and cost effectiveness of programs directed towards improvement of glycemic control and other cardiovascular risk factors in patients with T2D and T1D, the majority of these patients never achieve the goals established by guidelines issued by diabetes societies. <o:p></o:p></span></div>
<br />
<div class="MsoNormal" style="text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Contact details:</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Alina Grace</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Program Manager | Obesity Middle East 2019</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Email id: obesityendo@mehealthevents.org </span></div>
</div>
2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.com0tag:blogger.com,1999:blog-2208153697299485410.post-72242825206847800702019-01-18T02:44:00.001-08:002019-01-18T02:44:41.958-08:00Obesity and Clinical Endocrinology<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEimbSqRj_3U172LZUcKF7MhWdTHU5u50fzG-pMcFDFubl0W2D97xAXKFc1m8gn49f6tM-J_UjpYge5aQ5L9OqAEPArrdxADCQXL0p4AKq-cYIUmwCqo1_qGqpROjNEJoq5yKB8K3ps_umDZ/s1600/https___obesity-middleeast.conferenceseries.com_+%25281%2529.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="280" data-original-width="420" height="426" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEimbSqRj_3U172LZUcKF7MhWdTHU5u50fzG-pMcFDFubl0W2D97xAXKFc1m8gn49f6tM-J_UjpYge5aQ5L9OqAEPArrdxADCQXL0p4AKq-cYIUmwCqo1_qGqpROjNEJoq5yKB8K3ps_umDZ/s640/https___obesity-middleeast.conferenceseries.com_+%25281%2529.jpg" width="640" /></a></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="background: white; font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="background: white; font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Endocrine disrupting chemicals are commonly found in food and food containers, furniture, plastic products, toys, building materials, carpeting, and cosmetics. They are usually released from the products that contain them and enter the bodies of humans and wildlife through dust or through the food chain. A large volume of studies have shown that Endocrine disrupting chemicals exert their effects by interfering with endogenous hormone action and can impact male and female reproduction, breast development and cancer, prostate cancer, metabolism and obesity, <a href="https://obesity-middleeast.conferenceseries.com/events-list/neuroendocrinology">neuroendocrinology</a>, thyroid and cardiovascular endocrinology. <o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="background: white; font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="background: white; font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Critical endocrine principles that are relevant to risk assessment as it applies to Endocrine disrupting chemicals. In its Statement of Principles, the Society recommends that endocrine principles be incorporated into programs by the EPA and different agencies charged with evaluating chemicals for endocrine-disrupting potential.<o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="background: white; font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Several endocrine abnormalities are reported in <a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-its-causes">obesity</a>. A number of these abnormalities are considered as causative factors for the development of obesity, whereas others are considered to be secondary effects of obesity and usually are restored after weight loss. Thyroid hormones sometimes are normal in obesity, with the exception of T3 that is elevated. Prolactin is normal but prolactin response to various stimuli is blunted. Growth hormone is low and GH response to stimuli is blunted. IGF-I levels are normal or elevated. Cortisol, ACTH, and urine free cortisol levels are generally normal; however, a hyperresponsiveness of the HPA axis with enhanced cortisol and ACTH response to stimulatory tests is observed in centrally obese individuals. Total testosterone and SHBG levels are low, however free testosterone levels are typically normal in obese men. LH and FSH levels usually are normal and estrogens are elevated. Norepinephrine levels are elevated, though epinephrine levels are low or normal. Aldosterone levels are raised however renin activity is typically normal. Parathyroid hormone levels are elevated with normal serum calcium levels and enhanced urine calcium levels. Monogenic mutations that result in severe obesity have been described in few people. Likewise, several endocrine diseases have obesity as one their clinical signs. Hypothyroidism, GH and testosterone deficiency, Cushing's syndrome, polycystic ovarian syndrome, hypothalamic lesions, insulinoma and genetic syndromes often present with obesity. In most of these conditions, proper treatment of the primary disease results in weight reduction. Also, the fat cell has been observed to be an endocrine organ that produces several peptides that are bioactive and participate in the regulation of adipocyte function. <o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<br />
<div class="MsoNormal">
<span style="font-family: "Times New Roman","serif"; font-size: 12.0pt; line-height: 115%;">Contact details: <br />Alina Grace<br />Program Manager | Obesity Middle East 2019<br />Mail Id:</span><span lang="EN-US" style="font-family: "Times New Roman", serif; font-size: 12pt; line-height: 115%;"><a href="mailto:obesityendo@mehealthevents.org">obesityendo@mehealthevents.org</a><o:p></o:p></span></div>
</div>
2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.com0tag:blogger.com,1999:blog-2208153697299485410.post-58514863305346424752019-01-11T19:28:00.000-08:002019-01-11T20:27:42.872-08:00Genetics of Obesity<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="background: white; line-height: 20.4pt; text-align: justify; vertical-align: baseline;">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg4S0vTJ_2E3V77Ouw7vQmsv5tg77np_AVNh3FA5ZIDWiinZg3eXmkQEj6bbSXwQxiHTdc64n-xQymj9mCEZcu4ABdWiVwrXiMkG4cRaKOj1yoXGI3JbU69ZgPpcaSKoEWSILcJKXf8e8Bx/s1600/https___obesity-middleeast.conferenceseries.com_.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="757" data-original-width="1280" height="378" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg4S0vTJ_2E3V77Ouw7vQmsv5tg77np_AVNh3FA5ZIDWiinZg3eXmkQEj6bbSXwQxiHTdc64n-xQymj9mCEZcu4ABdWiVwrXiMkG4cRaKOj1yoXGI3JbU69ZgPpcaSKoEWSILcJKXf8e8Bx/s640/https___obesity-middleeast.conferenceseries.com_.jpg" width="640" /></a></div>
<br />
<br /></div>
<div style="background: white; line-height: 20.4pt; text-align: justify; vertical-align: baseline;">
Obesity is a major risk factor for cardiovascular diseases, pulmonary diseases like sleep apnoea, metabolic disorders, osteoarticular diseases, for several of the Similar types of cancer and for serious psychiatric illness. <a href="https://obesity-middleeast.conferenceseries.com/events-list/childhood-obesity-and-effects">Childhood obesity</a> is associated with early-onset type 2 diabetes and with increased mortality risk for coronary heart disease in adulthood. If the escalating population prevalence of obesity and its serious implications for public health are generally accepted [with some notable exceptions], its causes and physiological consequences at the individual level are still elusive. </div>
<div style="background: white; line-height: 20.4pt; text-align: justify; vertical-align: baseline;">
<o:p></o:p></div>
<div class="MsoNormal" style="text-align: justify;">
<h2>
<span style="font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><b>Types:</b></span></h2>
</div>
<div class="MsoNormal" style="text-align: justify;">
<h3>
<b><span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Rare familial obesity:</span></b></h3>
</div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Moreover a decade, <a href="https://obesity-middleeast.conferenceseries.com/events-list/genetics-of-obesity">obesity genetics</a> has been predominantly driven by research into syndromic obesity. The cloning of the mouse gene and its human homologue, leptin, proved to be a paradigm for the field that resulted in the identification of many genes involved in the regulation of appetite via the leptin-melanocortin pathway. These variants account for 5% of morbid human obesity and include leptin and its receptor.</span></div>
<div class="MsoNormal" style="text-align: justify;">
<h3>
<b><span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Common polygenic obesity:</span></b></h3>
</div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">The Human Obesity Gene Map summarizes the current situation in the field of common polygenic obesity. In any complex genetic disease, there are many unconfirmed genetic associations as some of these may be due to inadequate sample sizes for association studies of genes of modest effect or caused due to the inadequate examination of the genetic variation within these candidate genes.</span></div>
<div class="MsoNormal" style="text-align: justify;">
<h3>
<b><span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">GAD2: </span></b></h3>
</div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">The glutamic acid decarboxylase gene (GAD2) was first reported and recorded to be associated with obesity and feeding behaviors in morbidly obese adults, and this result was subsequently replicated in obese children. Moreover, an independent study failed to replicate these findings. These results illustrate the difficulty in determining whether a gene is truly associated with a complex genetic disease. </span></div>
<div class="MsoNormal" style="text-align: justify;">
<h3>
<b><span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Visfatin: </span></b></h3>
</div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Pre-B cell colony-enhancing factor (PBEF1) was identified as the first protein secreted by lymphocytes over 10 years ago. This finding has now been replicated. The initial visfatin paper was also reported that visfatin had insulin mimetic activity. This was supported by a report where visfatin levels were altered in T2D patients. </span></div>
<div class="MsoNormal" style="text-align: justify;">
<h3>
<b><span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Ghrelin/ghrelin receptor/obestatin: </span></b></h3>
</div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">The growth hormone secretagogue receptor (GHSR) was identified in the year of 1996 and its endogenous ligand ghrelin in 1999. However, the evidence for ghrelin is not required as clear with initial positive results, but latterly, some negative results. </span></div>
<div class="MsoNormal" style="text-align: justify;">
<h3>
<b><span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Bardet–Biedl syndrome genes: </span></b></h3>
</div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;">Bardet–Biedl syndrome genes are familial forms of obesity have been associated with common <a href="https://obesity-middleeast.conferenceseries.com/abstract-submission.php">obesity</a>, e.g. leptin, as well as the leptin receptor, were examined BBS gene variants for this possibility. Twelve SNPs along with BBS1, 2, 4 and 6 genes were selected and genotyped in adult and childhood obesity sample sets, with a total of 3242 subjects. <o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><br /></span></div>
<div style="background: white; line-height: 20.4pt; text-align: justify; vertical-align: baseline;">
</div>
<div class="MsoNormal">
<span style="color: #2a2a2a; font-family: "times new roman" , "serif"; font-size: 12.0pt; line-height: 115%;"><b>Contact details:</b><br />Alina Grace<br />Program Manager | Obesity Middle East 2019<br />Email Id: obesityendo@mehealthevents.org <o:p></o:p></span></div>
</div>
2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.com0tag:blogger.com,1999:blog-2208153697299485410.post-38424219340290316322019-01-05T01:01:00.000-08:002019-01-05T01:21:49.943-08:00Obesity and Diabetes<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhwSYsQcIlxHg2lsOG-UAO6v_w6eER9dXkTjBajDeVPI3moRIJktcg9_J8P6dHu-sIdpv96F-83b2cvRMJiCvZ8HwLJ7PBD-OQ9r_W3MD01bEQUqdpheC2rPOsSu6_znHniECf3b2331jmX/s1600/https___obesity-middleeast.conferenceseries.com_Add+heading.jpg" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" data-original-height="789" data-original-width="940" height="536" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhwSYsQcIlxHg2lsOG-UAO6v_w6eER9dXkTjBajDeVPI3moRIJktcg9_J8P6dHu-sIdpv96F-83b2cvRMJiCvZ8HwLJ7PBD-OQ9r_W3MD01bEQUqdpheC2rPOsSu6_znHniECf3b2331jmX/s640/https___obesity-middleeast.conferenceseries.com_Add+heading.jpg" width="640" /></a></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif";"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif";"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif";">Weight is likely the most essential factor in the advancement of insulin obstruction; however, science's comprehension of the chain of occasions is as yet spotty. Now researchers have developed possible outcomes for obesity sets the stage for </span><a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-diabetes"><span style="font-family: "times new roman" , "serif";">diabetes</span></a><span style="font-family: "times new roman" , "serif";"> and why thin people can become insulin-resistant. ER (endoplasmic reticulum) stress is the condition which is induced by a high-fat diet and is overly activated in obese people, triggers aberrant glucose production in the liver, an important step on the path for insulin resistance.<o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif";"><br /></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif";">In healthy people, a fasting switch possibly flips on glucose production when blood glucose levels run low during fasting. The existence of a second cellular cascade signalling—like an alternate route from A to B—that can modulate glucose production, shows the potential to distinguish new classes of medications that that may bring down glucose by disrupting this alternative pathway. It had been well established that </span><a href="https://obesity-middleeast.conferenceseries.com/events-list/obesity-and-its-causes"><span style="font-family: "times new roman" , "serif";">obesity</span></a><span style="font-family: "times new roman" , "serif";"> promotes insulin resistance through the inappropriate inactivation of a process called gluconeogenesis, where the liver creates glucose for fuel and which usually happens just during fasting. <o:p></o:p></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif";"><br /></span></div>
<span style="font-family: "times new roman" , serif; text-align: justify;">At the point when a cell begins to sense stress a red light goes on, which slows down the generation of proteins. This procedure, which is known as ER stress response, is abnormally active in livers of obese individuals, where it contributes to the development of high blood glucose levels or hyperglycemia. We asked whether chronic endoplasmic reticulum stress in obesity leads to abnormal activation of the fasting switch that usually controls glucose production in the liver. The endoplasmic reticulum, short for endoplasmic reticulum, is a protein factory within the cell. Endoplasmic reticulum stress can induce gluconeogenesis in lean mice. Glucose production is turned on by a transcriptional switch called CRTC2, which typically sits outside the nucleus waiting for the signal that allows it to slip inside and do its work. Once in the nucleus, it collaborates with a protein called CREB and together they switch on the genes necessary to increase glucose output. In insulin-resistant mice, however, the CRTC2 switch seems to get stuck in the "on" position and the cells begin producing glucose like sugar factories in overdrive. </span><br />
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: "times new roman" , "serif";"><br /></span> <span style="font-family: "times new roman" , "serif";">Contact details:</span><br />
<span style="font-family: "times new roman" , "serif";">Alina Grace</span><br />
<span style="font-family: "times new roman" , "serif";">Program Manager | Obesity Middle East 2019</span><br />
<span style="font-family: "times new roman" , "serif";">Mail Id: obesityendo@mehealthevents.org</span></div>
</div>
2nd Middle East Obesity, Bariatric Surgery and Endocrinology Congresshttp://www.blogger.com/profile/04184096911909416099noreply@blogger.com0